Synaptogenix, Inc., an emerging biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, commented on the positive Phase 3 trial results for Lecanemab announced last...
Cell coding company bit.bio has announced an expansion to its product portfolio - ioGlutamatergic Neurons TDP-43M337V disease model and early access to its ioMicroglia...
For nearly 20 years, Bionix has supplied the healthcare industry with its innovative and dependable Lighted Ear Curettes, designed to illuminate and improve visualization...
MolecuLight Corp., the leader in point-of-care fluorescence imaging for the real-time detection of bacteria in wounds, announces it has been awarded a new group...
Dr. YongHua Li conducted a clinical trial for EmeTerm, the anti-nausea wristband developed by WAT Medical Enterprise, Ltd., Vancouver, BC, Canada. The study spanned...
